drugset / Trial / NCT00557492
Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is to determine the efficacy of bevacizumab and gemcitabine in combination with radiation therapy in the preoperative treatment of potentially-resectable subjects with pancreatic cancer.
Timeline
- Start
- 2006-12
- Primary completion
- 2012-03
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 10 mg/kg | — |
| Subject | Gemcitabine | Small molecule | 1500 mg/m2 | Intravenous |